The electronic medication reconciliation documentation process developed and implemented at our institution could be adapted and implemented in other facilities. Requirements for successful ...
Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...
The results of this simulation model suggest that implementing a pharmacist-led medication reconciliation intervention at hospital discharge could be cost-saving compared with usual care. Objectives: ...
We conducted a prospective study in a 48-bed adult general medical unit of our hospital. The study investigators included pharmacists and nurses. Noninvestigators included pharmacists, nurses, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results